| LOT-0002 | Framework | Not specified | €743,027 | Antineoplastic agents (33652100), Immunoglobulins (33651520) |
| LOT-0042 | Framework | Not specified | €581,305 | Antineoplastic agents (33652100), Medicinal products used in diabetes (33615000) |
| LOT-0025 | Framework | Not specified | €555,984 | Antineoplastic agents (33652100), Cardiac therapy medicinal products (33622100) |
| LOT-0004 | Framework | Not specified | €546,495 | Antineoplastic agents (33652100), Immunoglobulins (33651520) |
| LOT-0031 | Framework | Not specified | €522,961 | Antineoplastic agents (33652100), General anti-infectives for systemic use and vaccines (33651000) |
| LOT-0030 | Framework | Not specified | €498,740 | Antineoplastic agents (33652100), Cardiac therapy medicinal products (33622100) |
| LOT-0008 | Framework | Not specified | €445,590 | Antineoplastic agents (33652100), Immunoglobulins (33651520) |
| LOT-0001 | Framework | Not specified | €348,667 | Antineoplastic agents (33652100), Immunoglobulins (33651520) |
| LOT-0009 | Framework | Not specified | €326,569 | Antineoplastic agents (33652100), Immunoglobulins (33651520) |
| LOT-0007 | Framework | Not specified | €321,946 | Antineoplastic agents (33652100), Immunoglobulins (33651520) |
| LOT-0018 | Framework | Not specified | €304,246 | Antineoplastic agents (33652100), Immunoglobulins (33651520) |
| LOT-0020 | Framework | Not specified | €293,947 | Antineoplastic agents (33652100), Immunoglobulins (33651520) |
| LOT-0027 | Framework | FARMACEUTICA REMEDIA DISTRIBUTION & LOGISTICS S.R.L. | €275,945 | Antineoplastic agents (33652100), Antihaemorrhagics (33621200) |
| LOT-0033 | Framework | Not specified | €235,274 | Antineoplastic agents (33652100), Cardiac therapy medicinal products (33622100) |
| LOT-0044 | Framework | Not specified | €176,244 | Antineoplastic agents (33652100) |
| LOT-0034 | Framework | Not specified | €158,001 | Antineoplastic agents (33652100), Cardiac therapy medicinal products (33622100) |
| LOT-0013 | Framework | Not specified | €156,235 | Antineoplastic agents (33652100), Immunoglobulins (33651520) |
| LOT-0035 | Framework | Not specified | €151,752 | Antineoplastic agents (33652100), Antivirals for systemic use (33651400) |
| LOT-0006 | Framework | MEDIPLUS EXIM | €84,123 | Antineoplastic agents (33652100), Immunoglobulins (33651520) |
| LOT-0067 | Framework | Not specified | €84,123 | Antineoplastic agents (33652100) |
| LOT-0012 | Framework | Not specified | €80,328 | Antineoplastic agents (33652100), Immunoglobulins (33651520) |
| LOT-0017 | Framework | Not specified | €77,525 | Antineoplastic agents (33652100), Immunoglobulins (33651520) |
| LOT-0019 | Framework | Not specified | €69,988 | Antineoplastic agents (33652100), Immunoglobulins (33651520) |
| LOT-0045 | Framework | Not specified | €65,694 | Antineoplastic agents (33652100) |
| LOT-0016 | Framework | Not specified | €59,162 | Antineoplastic agents (33652100), Immunoglobulins (33651520) |
| LOT-0039 | Framework | FRESENIUS KABI ROMANIA SRL | €55,005 | Antineoplastic agents (33652100), Medicinal products used in diabetes (33615000) |
| LOT-0048 | Framework | Not specified | €55,005 | Antineoplastic agents (33652100) |
| LOT-0015 | Framework | Not specified | €46,982 | Antineoplastic agents (33652100), Immunoglobulins (33651520) |
| LOT-0010 | Framework | Not specified | €45,006 | Antineoplastic agents (33652100), Immunoglobulins (33651520) |
| LOT-0041 | Framework | Not specified | €40,057 | Antineoplastic agents (33652100), Medicinal products used in diabetes (33615000) |
| LOT-0022 | Framework | FARMACEUTICA REMEDIA DISTRIBUTION & LOGISTICS S.R.L. | €32,658 | Antineoplastic agents (33652100), Immunoglobulins (33651520) |
| LOT-0026 | Framework | Not specified | €32,658 | Antineoplastic agents (33652100), Antihaemorrhagics (33621200) |
| LOT-0024 | Framework | Not specified | €31,868 | Antineoplastic agents (33652100), Immunoglobulins (33651520) |
| LOT-0011 | Framework | Not specified | €30,459 | Antineoplastic agents (33652100), Immunoglobulins (33651520) |
| LOT-0023 | Framework | Not specified | €23,020 | Antineoplastic agents (33652100), Immunoglobulins (33651520) |
| LOT-0036 | Framework | Not specified | €22,139 | Antineoplastic agents (33652100), General anti-infectives for systemic use and vaccines (33651000) |
| LOT-0043 | Framework | Not specified | €20,301 | Antineoplastic agents (33652100) |
| LOT-0003 | Framework | Not specified | €17,735 | Antineoplastic agents (33652100), Immunoglobulins (33651520) |
| LOT-0028 | Framework | Not specified | €17,735 | Antineoplastic agents (33652100), Antimycotics for systemic use (33651200) |
| LOT-0021 | Framework | Not specified | €15,341 | Antineoplastic agents (33652100), Immunoglobulins (33651520) |
| LOT-0029 | Framework | Not specified | €14,425 | Antineoplastic agents (33652100), Antimycotics for systemic use (33651200) |
| LOT-0038 | Framework | Not specified | €11,072 | Antineoplastic agents (33652100), Medicinal products used in diabetes (33615000) |
| LOT-0014 | Framework | Not specified | €8,627 | Antineoplastic agents (33652100), Immunoglobulins (33651520) |
| LOT-0032 | Framework | Not specified | €3,589 | Antineoplastic agents (33652100), Cardiac therapy medicinal products (33622100) |
| LOT-0005 | Framework | MEDIPLUS EXIM | €2,393 | Antineoplastic agents (33652100), Immunoglobulins (33651520) |
| LOT-0037 | Framework | MEDIPLUS EXIM | €2,393 | Antineoplastic agents (33652100), Medicinal products used in diabetes (33615000) |
| LOT-0055 | Framework | Not specified | €2,393 | Antineoplastic agents (33652100) |
| LOT-0056 | Framework | Not specified | €2,393 | Antineoplastic agents (33652100) |
| LOT-0040 | Framework | Not specified | €1,539 | Antineoplastic agents (33652100), Medicinal products used in diabetes (33615000) |
| LOT-0046 | Framework | Not specified | — | Antineoplastic agents (33652100) |
| LOT-0047 | Framework | Not specified | — | Antineoplastic agents (33652100) |
| LOT-0049 | Framework | Not specified | — | Antineoplastic agents (33652100) |
| LOT-0050 | Framework | Not specified | — | Antineoplastic agents (33652100) |
| LOT-0051 | Framework | Not specified | — | Antineoplastic agents (33652100) |
| LOT-0052 | Framework | Not specified | — | Antineoplastic agents (33652100) |
| LOT-0053 | Framework | Not specified | — | Antineoplastic agents (33652100) |
| LOT-0054 | Framework | Not specified | — | Antineoplastic agents (33652100) |
| LOT-0057 | Framework | Not specified | — | Antineoplastic agents (33652100) |
| LOT-0058 | Framework | Not specified | — | Antineoplastic agents (33652100) |
| LOT-0059 | Framework | Not specified | — | Antineoplastic agents (33652100) |
| LOT-0060 | Framework | Not specified | — | Antineoplastic agents (33652100) |
| LOT-0061 | Framework | Not specified | — | Antineoplastic agents (33652100) |
| LOT-0062 | Framework | Not specified | — | Antineoplastic agents (33652100) |
| LOT-0063 | Framework | Not specified | — | Antineoplastic agents (33652100) |
| LOT-0064 | Framework | Not specified | — | Antineoplastic agents (33652100) |
| LOT-0065 | Framework | Not specified | — | Antineoplastic agents (33652100) |
| LOT-0066 | Framework | Not specified | — | Antineoplastic agents (33652100) |
| LOT-0068 | Framework | Not specified | — | Antineoplastic agents (33652100) |